TW231970B - - Google Patents

Info

Publication number
TW231970B
TW231970B TW082103742A TW82103742A TW231970B TW 231970 B TW231970 B TW 231970B TW 082103742 A TW082103742 A TW 082103742A TW 82103742 A TW82103742 A TW 82103742A TW 231970 B TW231970 B TW 231970B
Authority
TW
Taiwan
Prior art keywords
pct
sec
date
date dec
pub
Prior art date
Application number
TW082103742A
Other languages
English (en)
Chinese (zh)
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Application granted granted Critical
Publication of TW231970B publication Critical patent/TW231970B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
TW082103742A 1992-05-07 1993-05-12 TW231970B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
TW231970B true TW231970B (enExample) 1994-10-11

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082103742A TW231970B (enExample) 1992-05-07 1993-05-12

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT1421939E (pt) * 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2011316225B2 (en) 2010-10-15 2016-05-19 Contera Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
BR112014025907B1 (pt) 2012-04-18 2023-02-14 Contera Pharma Aps Formulação farmacêutica disponível para administração por via oral adequada para manejo aprimorado de transtornos do movimento
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
FR2488606A1 (fr) * 1980-08-12 1982-02-19 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (enExample) * 1982-06-07 1984-10-22 Glaxo Group Ltd
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3542698A1 (de) * 1984-12-04 1986-06-05 Glaxo Group Ltd., London Indolderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
IL87437A0 (en) * 1987-08-13 1989-01-31 Glaxo Group Ltd Indole derivatives,their preparation and pharmaceutical compositions containing them
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
IL105468A0 (en) 1993-08-18
GB9309209D0 (en) 1993-06-16
SG46649A1 (en) 1998-02-20
IT1261471B (it) 1996-05-23
CZ272394A3 (en) 1995-10-18
CA2135179C (en) 2000-12-05
RU2118527C1 (ru) 1998-09-10
HU211638A9 (en) 1995-12-28
DE69317418D1 (de) 1998-04-16
ITRM930286A1 (it) 1994-11-06
CY2039B1 (en) 1998-04-30
GB2266665A (en) 1993-11-10
ATE163850T1 (de) 1998-03-15
ITRM930286A0 (it) 1993-05-06
CA2135179A1 (en) 1993-11-11
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
NO306700B1 (no) 1999-12-13
UA37206C2 (uk) 2001-05-15
HUT71418A (en) 1995-11-28
NZ252132A (en) 1996-09-25
ES2113533T3 (es) 1998-05-01
HK95697A (en) 1997-08-08
HU227338B1 (en) 2011-04-28
RO112993B1 (ro) 1998-03-30
IL105468A (en) 1998-09-24
CH685920A5 (fr) 1995-11-15
NO944214D0 (no) 1994-11-04
BR1100108A (pt) 1999-12-07
KR100253111B1 (en) 2000-07-01
GB2266665B (en) 1996-05-22
NO944214L (no) 1994-11-07
EP0639072A1 (en) 1995-02-22
IE930339A1 (en) 1993-11-17
AU4064093A (en) 1993-11-29
CZ283512B6 (cs) 1998-04-15
DE69317418T2 (de) 1998-07-30
GB9209882D0 (en) 1992-06-24
EP0639072B1 (en) 1998-03-11
IE75203B1 (en) 1997-08-27
OA10109A (en) 1996-12-18
BE1007024A5 (fr) 1995-02-21
WO1993021916A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
FR2690847B1 (fr) 1995-06-09
AU670083B2 (en) 1996-07-04
GR3026584T3 (en) 1998-07-31
US5705506A (en) 1998-01-06
ZA933178B (en) 1994-01-10
BG62120B1 (bg) 1999-03-31

Similar Documents

Publication Publication Date Title
MX9702865A (es) Agentes estrogenicos.
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
BG105534A (en) 5ht1 means and method for the treatment of migraine
EP0903349A3 (en) CCR-3 receptor antagonists
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
CA2366268A1 (en) Pharmaceutical compositions for cns and other disorders
GB2266665B (en) 5-HT1-like receptor agonist for rectal administration
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
MX9505064A (es) Composicion farmaceutica, aplicable oralmente.
MX9505065A (es) Composicion farmaceutica, aplicable oralmente.
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
WO2000000198A8 (en) Piperidine derivatives having effects on serotonin related systems
NO944781L (no) 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
GR3036195T3 (en) Novel compounds
BG102229A (en) Endothelium receptor antagonists
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
ATE162946T1 (de) Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen
DK1030659T3 (da) Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist
CA2270026A1 (en) Substituted bicyclic derivatives for treating central nervous system disorders
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих